Dementia Associated With Alzheimer's Disease Market Research Report 2024: Comprehensive Insights About 80+ Companies and 100+ Pipeline Drugs
21 nov. 2024 04h19 HE
|
Research and Markets
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Dementia Associated With Alzheimer's Disease - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This...
Neurologic Disorders Therapeutics Strategic Business Report 2024: Global Market to Reach $149.7 Billion by 2030, Driven by Development of Regenerative Medicine and Stem Cell Therapies
22 oct. 2024 09h43 HE
|
Research and Markets
Dublin, Oct. 22, 2024 (GLOBE NEWSWIRE) -- The "Neurologic Disorders Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Amyotrophic Lateral Sclerosis Market Report (2024 Edition): Size, Trends, Opportunities and Forecast by Treatment Type, Drug, Distribution Channel, and Country (2020-2030)
20 sept. 2024 08h02 HE
|
Research and Markets
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "Amyotrophic Lateral Sclerosis Market (2024 Edition): Size, Trends, Opportunities and Forecast by Treatment Type, Drug, Distribution Channel, and...
Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2024, Featuring Sanofi, Bristol Myers Squibb, Abbott Laboratories, Takeda Pharmaceutical and Amgen
08 mars 2024 04h28 HE
|
Research and Markets
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2024" has been added to ResearchAndMarkets.com's offering.The chemotherapy...
Neuropathix, Inc. Announces Publication of Its Global PCT Patent for NPTX-204, a Novel Hops-Inspired Neuroprotectant
19 janv. 2021 09h00 HE
|
Neuropathix, Inc.
DOYLESTOWN, Pa., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Neuropathix, Inc. (“Neuropathix” or the “Company”) (OTCQB: NPTX), a socially responsible pain management life sciences company, announced the...
Growth in Neuroprotective Agents Market Projected to 2022
18 juin 2018 06h00 HE
|
BCC Research
WELLESLEY, Mass., June 18, 2018 (GLOBE NEWSWIRE) -- Longer life spans, the increasing prevalence of neurological disorders (particularly neurodegenerative diseases), stroke and traumatic central...
Kannalife Sciences Discusses Orphan Drug Opportunity for KLS-13019
11 août 2015 13h50 HE
|
KannaLife Sciences, Inc.
NEW YORK, Aug. 11, 2015 (GLOBE NEWSWIRE) -- Kannalife Sciences, Inc., a Phyto-Medical Company, describes orphan drug opportunity for KLS-13019, a Novel Functionalized 1,3-Benzene Diol for the...
KannaLife Sciences Announces Publication of Its Global PCT Patent Covering Cannabidiol-like Neuroprotective Agents
06 août 2015 13h54 HE
|
KannaLife Sciences, Inc.
NEW YORK, Aug. 6, 2015 (GLOBE NEWSWIRE) -- KannaLife Sciences, Inc., a Phyto-Medical Company, announced the publication of its global WIPO/PCT Patent WO2015/106108A2 – 'Novel Functionalized...